Name | Aluminium Oxide + Magnesium Trisilicate |
Classes |
Antacid Gastrointestinal Agent |
Diseases |
Dyspepsia Gastrointestinal Disease GERD (Gastroesophageal Reflux Disease) Heart Burn Indigestion Sour Stomach |
Aluminium Oxide + Magnesium Trisilicate
Aluminium Oxide + Magnesium Trisilicate is a combination medication that exerts its action by reacting with the excess gastric acid produced in the stomach.
Aluminium Oxide + Magnesium Trisilicate is indicated for the following conditions-
- Gastric acidity
- Dyspepsia
- Flatulence
- Gastric ulcer
- Aluminium Oxide + Magnesium Trisilicate is available as chewable tablets and suspension.
- The usual dosage of the medication is 2-3 teaspoonfuls after every meal and before bedtime.
- Maximum frequency is 4 times a day.
Side effects of Aluminium Oxide + Magnesium Trisilicate include-
- diarrhea
- abdominal pain
- constipation
- nausea
- taste disturbance (metallic taste, chalky taste)
- milk-alkali syndrome
- Large doses of this product may trigger or aggravate intestinal obstruction and ileus in patients at higher risk, such as those with renal impairment or the elderly. Aluminium oxide may cause constipation, and magnesium salts overdose may cause hypomotility of the bowel; large doses of this product may trigger or aggravate intestinal obstruction and ileus in patients at higher risk, such as those with renal impairment or the elderly.
- Because aluminum oxide is poorly absorbed from the gastrointestinal tract, systemic effects in persons with normal renal function are uncommon. Excessive doses, long-term use, or even typical doses in individuals on low-phosphorus diets can cause phosphate depletion (due to aluminium-phosphate binding), accelerated bone resorption, hypercalciuria, and osteomalacia. Long-term use or people who are at danger of phosphate deficiency should seek medical guidance.
- Aluminium and magnesium levels in the blood rise in people with renal impairment. Long-term exposure to large dosages of aluminum and magnesium salts may cause dementia and microcytic anemia in these patients. Patients with porphyria who are receiving hemodialysis may be at risk from aluminum hydroxide.
- Caution should be exercised in patients with hypophosphatemia.
Contraindication
- Contraindicated in patients hypersensitive to any component of the medication.
- Coadministration with tetracycline and quinolone antibiotics is contraindicated-
There's no known contraindications of the medication in terms of food and drinks.
Contraindicated in patients with hypophosphatemia.